Osteoporosis in men

Journal of Osteoporosis

Volumn 2012, Issue , 2012, Pages

  Szulc, Pawel ^a   Kaufman, Jean Marc ^b   Orwoll, Eric S ^c  

^a UNIVERSITÉ DE LYON   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CARBOXY TERMINAL TELOPEPTIDE; DENOSUMAB; ESTRADIOL; SOMATOMEDIN C; TOREMIFENE; ZOLEDRONIC ACID;

ANDROGEN DEPRIVATION THERAPY; BONE DENSITY; BONE STRUCTURE; CERVICAL SPINE FRACTURE; DENSITOMETRY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIP FRACTURE; HUMAN; LIFESPAN; MEN'S HEALTH; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SEX DIFFERENCE; SPINE FRACTURE;

EID: 84876510847     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2012/675984     Document Type: Review

References (61)

1. Baron J. A., Karagas M., Barrett J., Kniffin W., Malenka D., Mayor M., Keller R. B., Basic epidemiology of fractures of the upper and lower limb among americans over 65 years of age. Epidemiology 1996 7 6 612 618 2-s2.0-0029806728 (Pubitemid 26353455)
2. Kiel D. P., Eichorn A., Intrator O., Silliman R. A., Mor V., The outcomes of patients newly admitted to nursing homes after hip fracture. American Journal of Public Health 1994 84 8 1281 1286 2-s2.0-0028148142 (Pubitemid 24250698)
3. Fransen M., Woodward M., Norton R., Robinson E., Butler M., Campbell A. J., Excess mortality or institutionalization after hip fracture: men are at greater risk than women. Journal of the American Geriatrics Society 2002 50 4 685 690 2-s2.0-0036216374 10.1046/j.1532-5415.2002.50163.x (Pubitemid 34298756)
4. Bliuc D., Nguyen N. D., Milch V. E., Nguyen T. V., Eisman J. A., Center J. R., Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. Journal of the American Medical Association 2009 301 5 513 521 2-s2.0-59649116770 10.1001/jama.2009.50
5. Trombetti A., Herrmann F., Hoffmeyer P., Schurch M. A., Bonjour J. P., Rizzoli R., Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporosis International 2002 13 9 731 737 2-s2.0-0036712959 10.1007/s001980200100 (Pubitemid 35001001)
6. Leslie W. D., O'Donnell S., Jean S., Lagacé C., Walsh P., Bancej C., Morin S., Hanley D. A., Papaioannou A., Trends in hip fracture rates in Canada. Journal of the American Medical Association 2009 302 8 883 889 2-s2.0-69249208815 10.1001/jama.2009.1231
7. Abrahamsen B., Vestergaard P., Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 19972006. Osteoporosis International 2010 21 3 373 380 2-s2.0-76549108775 10.1007/s00198-009-0957-3
8. Fisher A. A., O'Brien E. D., Davis M. W., Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy. Bone 2009 45 2 246 253 2-s2.0-67649435983 10.1016/j.bone.2009.04.244
9. Maravic M., Taupin P., Landais P., Roux C., Change in hip fracture incidence over the last 6 years in France. Osteoporosis International 2011 22 3 797 801 2-s2.0-77952749130 10.1007/s00198-010-1255-9
10. Chevalley T., Guilley E., Herrmann F. R., Hoffmeyer P., Rapin C. H., Rizzoli R., Incidence of hip fracture over a 10-year period (19912000): reversal of a secular trend. Bone 2007 40 5 1284 1289 2-s2.0-34047267342 10.1016/j.bone.2006.12.063 (Pubitemid 46550978)
11. Icks A., Haastert B., Wildner M., Becker C., Meyer G., Trend of hip fracture incidence in Germany 19952004: a population-based study. Osteoporosis International 2008 19 8 1139 1145 2-s2.0-46649102294 10.1007/s00198-007-0534-6
12. Hagino H., Furukawa K., Fujiwara S., Okano T., Katagiri H., Yamamoto K., Teshima R., Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan. Osteoporosis International 2009 20 4 543 548 2-s2.0-62149118697 10.1007/s00198-008-0685-0
13. Szulc P., Munoz F., Duboeuf F., Marchand F., Delmas P. D., Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study. Osteoporosis International 2005 16 10 1184 1192 2-s2.0-25844500306 10.1007/s00198-005-1970-9 (Pubitemid 41396945)
14. Schuit S. C., van der Klift M., Weel A. E., De Laet C. E. D. H., Burger H., Seeman E., Hofman A., Uitterlinden A. G., Van Leeuwen J. P. T. M., Pols H. A. P., Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 2004 34 1 195 202 2-s2.0-0942268144 10.1016/j.bone.2003.10.001 (Pubitemid 38142449)
15. Fink H. A., Blackwell T. L., Taylor B. C., Distribution and rate of clinical fractures in older men without osteoporosis: the osteoporotic fractures in men (MrOS) study. Journal of Bone and Mineral Research 2008 23 supplement 1 S79, article 1282
16. Writing Group for the ISCD Position Development Conference, Diagnosis of osteoporosis in men, premenopausal women, and children. Journal of Clinical Densitometry 2004 7 1 17 26 10.1385/JCD:7:1:17 (Pubitemid 38223461)
17. Kanis J. A., McCloskey E. V., Johansson H., Oden A., Melton L. J., Khaltaev N., A reference standard for the description of osteoporosis. Bone 2008 42 3 467 475 2-s2.0-39149120827 10.1016/j.bone.2007.11.001
18. Szulc P., Montella A., Delmas P. D., High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study. Annals of the Rheumatic Diseases 2008 67 9 1249 1255 2-s2.0-50249164343 10.1136/ard.2007.077941
19. Bauer D. C., Garnero P., Harrison S. L., Cauley J. A., Eastell R., Ensrud K. E., Orwoll E., Biochemical markers of bone turnover, hip bone loss, and fracture in older men: the MrOS study. Journal of Bone and Mineral Research 2009 24 12 2032 2038 2-s2.0-73849146589 10.1359/jbmr.090526
20. Bauer D. C., Ewing S. K., Cauley J. A., Ensrud K. E., Cummings S. R., Orwoll E. S., Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporosis International 2007 18 6 771 777 2-s2.0-34247567842 10.1007/s00198-006-0317-5 (Pubitemid 46684789)
21. Black D. M., Bouxsein M. L., Marshall L. M., Cummings S. R., Lang T. F., Cauley J. A., Ensrud K. E., Nielson C. M., Orwoll E. S., Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. Journal of Bone and Mineral Research 2008 23 8 1326 1333 2-s2.0-47849099623 10.1359/jbmr.080316 (Pubitemid 352040188)
22. Taes Y., Lapauw B., Griet V., De Bacquer D., Goemaere S., Zmierczak H., Kaufman J. M., Prevalent fractures are related to cortical bone geometry in young healthy men at age of peak bone mass. Journal of Bone and Mineral Research 2010 25 6 1433 1440 2-s2.0-77953483641 10.1002/jbmr.17
23. Szulc P., pawel.szulc@inserm.fr Boutroy S., Vilayphiou N., Chaitou A., Delmas P. D., Chapurlat R., Cross-sectional analysis of the association between fragility fractures and bone microarchitecture in older men: the STRAMBO study. Journal of Bone and Mineral Research 2011 26 6 1358 1367 10.1002/jbmr.319
24. Nguyen N. D., Frost S. A., Center J. R., Eisman J. A., Nguyen T. V., Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporosis International 2007 18 8 1109 1117 2-s2.0-34347382021 10.1007/s00198-007-0362-8 (Pubitemid 47020008)
25. Blaizot S., Delmas P. D., Marchand F., Chapurlat R., Szulc P., Risk factors for peripheral fractures vary by age in older men-the prospective MINOS study. Osteoporosis International 2011 22 1755 1764 2-s2.0-77956430168 10.1007/s00198-010-1386-z
26. Fraser L. A., Langsetmo L., Berger C., Ioannidis G., Goltzman D., Adachi J. D., Papaioannou A., Josse R., Kovacs C. S., Olszynski W. P., Towheed T., Hanley D. A., Kaiser S. M., Prior J., Jamal S., Kreiger N., Brown J. P., Johansson H., Oden A., McCloskey E., Kanis J. A., Leslie W. D., Fracture prediction and calibration of a Canadian FRAX tool: a population-based report from CaMos. Osteoporosis International 2011 22 3 829 837 2-s2.0-78649981835 10.1007/s00198-010-1465-1
27. Sandhu S. K., Nguyen N. D., Center J. R., Pocock N. A., Eisman J. A., Nguyen T. V., Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporosis International 2010 21 5 863 871 2-s2.0-77951255994 10.1007/s00198-009-1026-7
28. Szulc P., Munoz F., Duboeuf F., Marchand F., Delmas P. D., Low width of tubular bones is associated with increased risk of fragility fracture in elderly menthe MINOS study. Bone 2006 38 4 595 602 2-s2.0-33644985446 10.1016/j.bone.2005.09.004
29. Rivadeneira F., Houwing-Duistermaat J. J., Beck T. J., Janssen J. A. M. J. L., Hofman A., Pols H. A. P., Van Duijn C. M., Uitterlinden A. G., The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam study. Journal of Bone and Mineral Research 2004 19 8 1280 1290 2-s2.0-16644367476 10.1359/JBMR.040405 (Pubitemid 41094369)
30. Pulkkinen P., Partanen J., Jalovaara P., Jämsä T., BMD T-score discriminates trochanteric fractures from unfractured controls, whereas geometry discriminates cervical fracture cases from unfractured controls of similar BMD. Osteoporosis International 2010 21 1269 1276 2-s2.0-70349408522 10.1007/s00198-009-1070-3
31. Orwoll E. S., Marshall L. M., Nielson C. M., Cummings S. R., Lapidus J., Cauley J. A., Ensrud K., Lane N., Hoffmann P. R., Kopperdahl D. L., Keaveny T. M., Finite element analysis of the proximal femur and hip fracture risk in older men. Journal of Bone and Mineral Research 2009 24 3 475 483 2-s2.0-61849141278 10.1359/jbmr.081201
32. Wang X., Sanyal A., Cawthon P. M., Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. Journal of Bone and Mineral Research 2012 27 4 808 816 10.1002/jbmr.1539
33. Bauer D. C., Garnero P., Litwack Harrison S., Type I collagen isomerization (Alpha/Beta CTX Ratio) and risk of clinical vertebral fracture in men: a prospective study.
34. LeBlanc E. S., Nielson C. M., Marshall L. M., Lapidus J. A., Barrett-Connor E., Ensrud K. E., Hoffman A. R., Laughlin G., Ohlsson C., Orwoll E. S., The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. Journal of Clinical Endocrinology and Metabolism 2009 94 9 3337 3346 2-s2.0-69949092976 10.1210/jc.2009-0206
35. Amin S., Zhang Y., Felson D. T., Sawin C. T., Hannan M. T., Wilson P. W. F., Kiel D. P., Estradiol, testosterone, and the risk for hip fractures in elderly men from the framingham study. American Journal of Medicine 2006 119 5 426 433 2-s2.0-33646489631 10.1016/j.amjmed.2005.10.048
36. Mellström D., Vandenput L., Mallmin H., Holmberg A. H., Lorentzon M., Odén A., Johansson H., Orwoll E. S., Labrie F., Karlsson M. K., Ljunggren Ö.., Ohlsson C., Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. Journal of Bone and Mineral Research 2008 23 10 1552 1560 2-s2.0-52949150044 10.1359/jbmr.080518
37. Cauley J. A., Parimi N., Ensrud K. E., Bauer D. C., Cawthon P. M., Cummings S. R., Hoffman A. R., Shikany J. M., Barrett-Connor E., Orwoll E., Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men. Journal of Bone and Mineral Research 2010 25 3 545 553 2-s2.0-77953429257 10.1359/jbmr.090826
38. Melhus H., Snellman G., Gedeborg R., Byberg L., Berglund L., Mallmin H., Hellman P., Blomhoff R., Hagström E., Ärnlöv J., Michaëlsson K., Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. Journal of Clinical Endocrinology and Metabolism 2010 95 6 2637 2645 2-s2.0-77954484039 10.1210/jc.2009-2699
39. Ohlsson C., Claes.Ohlsson@medic.gu.se Mellström D., Carlzon D., Orwoll E., Ljunggren Ö., Karlsson M. K., Vandenput L., Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. Journal of Bone and Mineral Research 2011 26 4 865 872 10.1002/jbmr.281
40. Langlois J. A., Rosen C. J., Visser M., Hannan M. T., Harris T., Wilson P. W. F., Kiel D. P., Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham heart study. Journal of Clinical Endocrinology and Metabolism 1998 83 12 4257 4262 2-s2.0-0032452531 (Pubitemid 29100118)
41. Szulc P., Joly-Pharaboz M. O., Marchand F., Delmas P. D., Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study. Calcified Tissue International 2004 74 4 322 329 2-s2.0-1842632364 10.1007/s00223-003-0090-9 (Pubitemid 38480855)
42. Mirza M. A., Karlsson M. K., Mellström D., Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. Journal of Bone and Mineral Research 2011 26 4 857 864
43. Boonen S., Orwoll E. S., Wenderoth D., Stoner K. J., Eusebio R., Delmas P. D., Once-weekly risedronate in men with osteoporosis: results of a 2-Year, placebo-controlled, double-blind, multicenter study. Journal of Bone and Mineral Research 2009 24 4 719 725 2-s2.0-65549099590 10.1359/jbmr.081214
44. Orwoll E. S., Binkley N. C., Lewiecki E. M., Gruntmanis U., Fries M. A., Dasic G., Efficacy and safety of monthly ibandronate in men with low bone density. Bone 2010 46 4 970 976 2-s2.0-77950545056 10.1016/j.bone.2009.12.034
45. Orwoll E. S., Miller P. D., Adachi J. D., Brown J., Adler R. A., Kendler D., Bucci-Rechtweg C., Readie A., Mesenbrink P., Weinstein R. S., Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. Journal of Bone and Mineral Research 2010 25 10 2239 2250 2-s2.0-77954258511 10.1002/jbmr.119
46. Trovas G. P., Lyritis G. P., Galanos A., Raptou P., Constantelou E., A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers. Journal of Bone and Mineral Research 2002 17 3 521 527 2-s2.0-0036183610 (Pubitemid 34171767)
47. Orwoll E. S., Scheele W. H., Paul S., Adami S., Syversen U., Diez-Perez A., Kaufman J. M., Clancy A. D., Gaich G. A., The effect of teriparatide [human parathyroid hormone (134)] therapy on bone density in men with osteoporosis. Journal of Bone and Mineral Research 2003 18 1 9 17 2-s2.0-0037214255 10.1359/jbmr.2003.18.1.9 (Pubitemid 36008334)
48. Orwoll E., Ettinger M., Weiss S., Miller P., Kendler D., Graham J., Adami S., Weber K., Lorenc R., Pietschmann P., Vandormael K., Lombardi A., Alendronate for the treatment of osteoporosis in men. The New England Journal of Medicine 2000 343 9 604 610 2-s2.0-0034739277 10.1056/NEJM200008313430902 (Pubitemid 30659471)
49. Ringe J. D., Dorst A., Faber H., Ibach K., Alendronate treatment of established primary osteoporosis in men: 3-Year results of a prospective, comparative, two-arm study. Rheumatology International 2004 24 2 110 113 2-s2.0-1642390688 10.1007/s00296-003-0388-y (Pubitemid 38388755)
50. Zhong Z. M., Chen J. T., Anti-fracture efficacy of risedronic acid in men: a meta-analysis of randomized controlled trials. Clinical Drug Investigation 2009 29 5 349 357 2-s2.0-65249100154 10.2165/00044011-200929050- 00007
51. Kaufman J. M., Orwoll E., Goemaere S., San Martin J., Hossain A., Dalsky G. P., Lindsay R., Mitlak B. H., Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporosis International 2005 16 5 510 516 2-s2.0-22844447275
52. Smith M. R., Egerdie B., Toriz N. H., Feldman R., Tammela T. L. J., Saad F., Heracek J., Szwedowski M., Ke C., Kupic A., Leder B. Z., Gossl C., Denosumab in men receiving androgen-deprivation therapy for prostate cancer. The New England Journal of Medicine 2009 361 8 745 755 2-s2.0-69049105440 10.1056/NEJMoa0809003
53. Smith M. R., Morton R. A., Barnette K. G., Sieber P. R., Malkowicz S. B., Rodriguez D., Hancock M. L., Steiner M. S., Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. Journal of Urology 2010 184 4 1316 1321 2-s2.0-77955537343 10.1016/j.juro.2010.06.022
54. Smith M. R., smith.matthew@mgh.harvard.edu Malkowicz S. B., Brawer M. K., Hancock M. L., Morton R. A., Steiner M. S., Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer. Journal of Urology 2011 186 6 2239 2244 10.1016/j.juro.2011.07.090
55. Boonen S., Su G., Incera E., Antifracture efficacy and safety of once-yearly zoledronic acid 5 mg in men with osteoporosis: a prospective, randomized, controlled trial. Osteoporosis International 2011 22 supplement 1
56. Haentjens P., Johnell O., Kanis J. A., Bouillon R., Cooper C., Lamraski G., Vanderschueren D., Kaufman J. M., Boonen S., Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white men. Journal of Bone and Mineral Research 2004 19 12 1933 1944 2-s2.0-21644473494 10.1359/JBMR.040917 (Pubitemid 41103407)
57. Panneman M. J., Lips P., Sen S. S., Herings R. M. C., Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporosis International 2004 15 2 120 124 2-s2.0-1342332570 10.1007/s00198-003-1544-7 (Pubitemid 38252425)
58. Feldstein A. C., Nichols G., Orwoll E., Elmer P. J., Smith D. H., Herson M., Aickin M., The near absence of osteoporosis treatment in older men with fractures. Osteoporosis International 2005 16 8 953 962 2-s2.0-23744458930 10.1007/s00198-005-1950-0 (Pubitemid 41127105)
59. Kiebzak G. M., Beinart G. A., Perser K., Ambrose C. G., Siff S. J., Heggeness M. H., Undertreatment of osteoporosis in men with hip fracture. Archives of Internal Medicine 2002 162 19 2217 2222 2-s2.0-0037190692 10.1001/archinte.162.19.2217 (Pubitemid 35231591)
60. Chitre M. M., Hayes W., 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan. Journal of Managed Care Pharmacy 2008 14 3 281 290 2-s2.0-44049107899 (Pubitemid 351711979)
61. Brown J. E., Sherriff J. M., James N. D., Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing, but under-recognized problem. BJU International 2010 105 8 1042 1043 2-s2.0-77950239175 10.1111/j.1464-410X.2010.09251.x